Suppr超能文献

健康志愿者中致幻蘑菇反应的预测。

Prediction of psilocybin response in healthy volunteers.

机构信息

Neuropsychopharmacology and Brain Imaging & Heffter Research Center, University Hospital of Psychiatry, Zurich, Switzerland.

出版信息

PLoS One. 2012;7(2):e30800. doi: 10.1371/journal.pone.0030800. Epub 2012 Feb 17.

Abstract

Responses to hallucinogenic drugs, such as psilocybin, are believed to be critically dependent on the user's personality, current mood state, drug pre-experiences, expectancies, and social and environmental variables. However, little is known about the order of importance of these variables and their effect sizes in comparison to drug dose. Hence, this study investigated the effects of 24 predictor variables, including age, sex, education, personality traits, drug pre-experience, mental state before drug intake, experimental setting, and drug dose on the acute response to psilocybin. The analysis was based on the pooled data of 23 controlled experimental studies involving 409 psilocybin administrations to 261 healthy volunteers. Multiple linear mixed effects models were fitted for each of 15 response variables. Although drug dose was clearly the most important predictor for all measured response variables, several non-pharmacological variables significantly contributed to the effects of psilocybin. Specifically, having a high score in the personality trait of Absorption, being in an emotionally excitable and active state immediately before drug intake, and having experienced few psychological problems in past weeks were most strongly associated with pleasant and mystical-type experiences, whereas high Emotional Excitability, low age, and an experimental setting involving positron emission tomography most strongly predicted unpleasant and/or anxious reactions to psilocybin. The results confirm that non-pharmacological variables play an important role in the effects of psilocybin.

摘要

人们认为,致幻剂(如裸盖菇素)的反应极大地取决于使用者的个性、当前情绪状态、药物使用前的经验、期望以及社会和环境变量。然而,人们对这些变量的重要性顺序及其与药物剂量相比的效应大小知之甚少。因此,本研究调查了 24 个预测变量(包括年龄、性别、教育程度、人格特质、药物使用前的经验、药物摄入前的精神状态、实验环境和药物剂量)对裸盖菇素急性反应的影响。该分析基于涉及 409 次裸盖菇素给药给 261 名健康志愿者的 23 项对照实验研究的汇总数据。对 15 个反应变量中的每一个都拟合了多元线性混合效应模型。尽管药物剂量显然是所有测量反应变量的最重要预测因子,但一些非药理学变量对裸盖菇素的影响也有显著贡献。具体而言,在吸收人格特质方面得分较高、在药物摄入前处于情绪激动和活跃状态以及过去几周内经历的心理问题较少,与愉快和神秘型体验密切相关,而情绪激动性高、年龄较低以及涉及正电子发射断层扫描的实验环境则最强烈地预测了对裸盖菇素的不愉快和/或焦虑反应。结果证实,非药理学变量在裸盖菇素的作用中起着重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9884/3281871/c8896e25ba77/pone.0030800.g001.jpg

相似文献

1
Prediction of psilocybin response in healthy volunteers.
PLoS One. 2012;7(2):e30800. doi: 10.1371/journal.pone.0030800. Epub 2012 Feb 17.
2
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects.
Psychopharmacology (Berl). 2011 Dec;218(4):649-65. doi: 10.1007/s00213-011-2358-5. Epub 2011 Jun 15.
5
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.
Psychopharmacology (Berl). 2006 Aug;187(3):268-83; discussion 284-92. doi: 10.1007/s00213-006-0457-5. Epub 2006 Jul 7.
6
High dose psilocybin is associated with positive subjective effects in healthy volunteers.
J Psychopharmacol. 2018 Jul;32(7):770-778. doi: 10.1177/0269881118780713. Epub 2018 Jun 27.
7
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.
J Psychopharmacol. 2011 Nov;25(11):1453-61. doi: 10.1177/0269881111420188. Epub 2011 Sep 28.
8
Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans.
J Psychopharmacol. 2021 Apr;35(4):459-468. doi: 10.1177/0269881120959609. Epub 2020 Oct 8.
9
Replication and extension of a model predicting response to psilocybin.
Psychopharmacology (Berl). 2019 Nov;236(11):3221-3230. doi: 10.1007/s00213-019-05279-z. Epub 2019 Jun 15.
10

引用本文的文献

1
Safety pharmacology of acute psilocybin administration in healthy participants.
Neurosci Appl. 2024 Mar 16;3:104060. doi: 10.1016/j.nsa.2024.104060. eCollection 2024.
3
A review of psychedelics trials completed in depression, informed by European regulatory perspectives.
Neurosci Appl. 2025 Feb 26;4:105516. doi: 10.1016/j.nsa.2025.105516. eCollection 2025.
4
Acute effects of psilocybin on the dynamics of gaze fixations during visual aesthetic perception.
Sci Rep. 2025 Jul 9;15(1):24763. doi: 10.1038/s41598-025-10206-8.
5
Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression.
J Psychopharmacol. 2025 Jul 1;39(9):2698811251346697. doi: 10.1177/02698811251346697.
6
Trait absorption is not reliably associated with brain structure or resting-state functional connectivity.
Neuroimage Rep. 2023 Apr 8;3(2):100171. doi: 10.1016/j.ynirp.2023.100171. eCollection 2023 Jun.
9
Aesthetic quality of psychedelic experience is linked to insight and psychological outcomes.
Front Psychol. 2025 May 15;16:1533055. doi: 10.3389/fpsyg.2025.1533055. eCollection 2025.
10
What are set and setting: Reducing vagueness to improve research and clinical practice.
J Psychopharmacol. 2025 May 26:2698811251337372. doi: 10.1177/02698811251337372.

本文引用的文献

1
Suppressing Unwanted Memories Reduces Their Unintended Influences.
Curr Dir Psychol Sci. 2017 Apr;26(2):197-206. doi: 10.1177/0963721417689881. Epub 2017 Apr 6.
2
Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.
J Psychopharmacol. 2011 Nov;25(11):1434-52. doi: 10.1177/0269881110382466. Epub 2010 Sep 20.
3
Psychometric evaluation of the altered states of consciousness rating scale (OAV).
PLoS One. 2010 Aug 31;5(8):e12412. doi: 10.1371/journal.pone.0012412.
4
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.
Nat Rev Neurosci. 2010 Sep;11(9):642-51. doi: 10.1038/nrn2884. Epub 2010 Aug 18.
6
Effectiveness of a marijuana expectancy manipulation: Piloting the balanced-placebo design for marijuana.
Exp Clin Psychopharmacol. 2009 Aug;17(4):217-25. doi: 10.1037/a0016502.
7
Psychedelics and schizophrenia.
Trends Neurosci. 2009 Apr;32(4):225-32. doi: 10.1016/j.tins.2008.12.005. Epub 2009 Mar 5.
8
Serotonin research: contributions to understanding psychoses.
Trends Pharmacol Sci. 2008 Sep;29(9):445-53. doi: 10.1016/j.tips.2008.06.006.
9
An R2 statistic for fixed effects in the linear mixed model.
Stat Med. 2008 Dec 20;27(29):6137-57. doi: 10.1002/sim.3429.
10
Human hallucinogen research: guidelines for safety.
J Psychopharmacol. 2008 Aug;22(6):603-20. doi: 10.1177/0269881108093587. Epub 2008 Jul 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验